Discover trends, market shifts, and competitive outlooks for the real-time pcr, digital pcr and end-point pcr industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Real-Time PCR, Digital PCR And End-Point PCR Market From 2025 To 2029?
In recent times, the market size of real-time pcr, digital pcr and end-point pcr has witnessed substantial growth. The market is forecasted to increase in size from $38.37 billion in 2024 to $41.88 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%. Factors leading to this growth in the historic period include the standardization of PCR protocols, its role in personalized medicine, contribution to the process of drug discovery and development, as well as its use in forensic and paternity testing.
Over the next several years, the market for real-time pcr, digital pcr and end-point pcr is anticipated to witness robust growth, reaching a value of $60.91 billion by 2029, with a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the forecast period include the expansion of molecular diagnostics, increased infectious disease testing, the growing demand for genetic testing, penetration in research and forensics markets, and the introduction of rapid point-of-care PCR solutions. Trends to observe in the forecast period include the advent of digital assays, advancements in multiplex PCR, a shift towards digital PCR technology, automation and high-throughput systems, and the miniaturization of PCR platforms.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp
What External and Internal Drivers Are Contributing to the Growth of the Real-Time PCR, Digital PCR And End-Point PCR Market?
The growth of real-time PCR, digital PCR, and end-point PCR markets is projected to be fuelled by a rise in contagious disease occurrences. Such diseases are brought on by the invasion and rapid propagation of harmful microorganisms such as bacteria, viruses, fungi, and parasites. Techniques like real-time PCR, digital PCR, and end-point PCR find usage in these diseases to quantify particular pathogens or their genetic content, track disease development, and quickly detect infections including HIV, hepatitis, respiratory viruses, and tuberculosis. For example, UNAIDS – a Switzerland-based UN program addressing the global HIV/AIDS epidemic – reported that the worldwide population living with HIV expanded to 39 million in 2022, a rise of 3.17% from 37.7 million in 2020. Additionally, 2022 saw approximately 1.3 million new HIV infections. Moreover, the US-based national public health organization, Centers for Disease Control and Prevention, stated in March 2023 that in the United States, the number of tuberculosis (TB) cases in 2022 rose to 8,300, a clear increase from 7,874 cases in 2021. Therefore, the cephalosporin market is expected to grow due to the increasing incidence of infectious diseases.
Real-Time PCR, Digital PCR And End-Point PCR Market Driver: Growth Potential for PCR Technologies With Rising Chronic Diseases
What Segment Types Define the Real-Time PCR, Digital PCR And End-Point PCR Market Structure?
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented –
1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations
Subsegments:
1) By Instruments: Real-Time PCR Systems, Digital PCR Systems, End-Point PCR Systems
2) By Consumables And Reagents: PCR Plates And Tubes, Primers And Probes, PCR Master Mix, DNA Polymerases And Nucleotides
3) By Software And Services: Analysis Software, Data Management Software, Calibration And Maintenance Services, Training And Support Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13296&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Real-Time PCR, Digital PCR And End-Point PCR Market?
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time PCR, digital PCR and end-point PCR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Long-Term Trends Are Transforming the Competitive Landscape of the Real-Time PCR, Digital PCR And End-Point PCR Market?
Key players in the markets of real-time PCR, digital PCR, and end-point PCR are innovating products via cutting-edge technologies such as digital polymerase chain reaction (dPCR) technology, a tool used for more comprehensive understanding of a patient’s cancer, genetic illness, or infection. Serving as an advanced version of traditional PCR methods, dPCR technology aids in the direct quantification and clonal amplification of several nucleic acid strands like DNA, cDNA, or RNA. Take, for example, Roche Diagnostics, a US-based pharmaceuticals and medical devices manufacturer. In August 2022, they launched a next-generation digital PCR system known as the Digital LightCycler System, built for early detection and treatment of a range of chronic and genetic diseases. The system eliminates external software, calculations, and processors, offering automated workflow and data management. It combines three nano well plate configurations, six advanced optical channels, and 5x concentrated DNA and RNA master mixes to deliver high sensitivity and precision. Adding valuable strength to Roche’s diagnostic platform portfolio, the Digital LightCycler System brings with it high-end technology, clinical applications, customization and flexibility, and automated workflow.
View the full report here:
What Is the Definition of the Real-Time PCR, Digital PCR And End-Point PCR Market?
Real-time PCR (polymerase chain reaction), digital PCR, and endpoint PCR are different techniques in molecular biology and genetic analysis used to amplify and analyze DNA samples. Real-time polymerase chain reaction (PCR) is a laboratory technique to amplify and quantify DNA or RNA molecules. Digital PCR is the third generation of PCR that enables precise quantification by segregating a sample into numerous isolated compartments. Endpoint PCR, or conventional PCR, refers to a fundamental molecular biology technique used to amplify a specific DNA sequence from a sample. These PCR techniques are used in various clinical applications, such as bacteria detection, DNA fingerprinting, and genetic disorder diagnosis.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13296
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
